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Abstract In microvascular transport, where both blood
and drug carriers are involved, plasma skimming has a
key role on changing hematocrit level and drug carrier
concentration in capillary beds after continuous vessel
bifurcation in the microvasculature. While there have
been numerous studies on modeling the plasma skim-
ming of blood, previous works lacked in consideration of
its interaction with drug carriers. In this paper, a gen-
eralized plasma skimming model is suggested to predict
the redistributions of both the cells and drug carriers
at each bifurcation. In order to examine its applicabil-
ity, this new model was applied on a single bifurcation
system to predict the redistribution of red blood cells
and drug carriers. Furthermore, this model was tested
at microvascular network level under different plasma
skimming conditions for predicting the concentration
of drug carriers. Based on these results, the applicabil-
ity of this generalized plasma skimming model is fully
discussed and future works along with the model’s lim-
itations are summarized.
Keywords Plasma skimming · Microvascular trans-
port · Drug carrier · Nanomedicine
1 Introduction
Drug carriers with chemotherapeutic agents are admin-
istrated to macrocirculatory systems for efficient diag-
nosis and treatment of various diseases (Jain and Stylianopoulos
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2010; Peer et al. 2007). In order to deliver drug carriers
in diseased areas, the geometric difference between nor-
mal and diseased areas of microvasculatures is mainly
considered (Chauhan et al. 2012). For this reason, good
understanding of the physics of drug carriers in the mi-
crovasculature holds significant importance. Related to
this topic, several experiments were performed to quan-
tify the drug carrier distributions in vitro (Saadatmand et al.
2011; Tan et al. 2016) and in vivo (Chauhan et al. 2012;
Kamoun et al. 2010; van de Ven et al. 2012). Even though
these experimental works suggested good methods at
single vessel and single bifurcation level, quantitative
measurement of the drug carrier concentration in the
entire microvasculature still remains as a challenge.
An alternative way of predicting the drug carrier
distribution is to develop a mathematical model that
can estimate the targeting efficiency of drug carriers in
the microvasculature. Several computational methods
were suggested and conducted to simulate various inter-
actions between cells and drug carriers (Lee et al. 2013,
2014; Mu¨ller et al. 2014; Tan et al. 2016). Although the
blood flow simulations with drug carriers in a microves-
sel are possible, Computational Fluid Dynamics (CFD)
simulation of cells and drug carriers in the entire mi-
crovasculature has not been reported yet due to its
tremendous efforts for a test-run. Meanwhile, mathe-
matical models have been utilized to simplify the blood
flow in microvessels by applying Poiseuille’s law with
the in vivo viscosity law (Pries et al. 1996) to calculate
the blood flow in microvessels, along with conservation
of mass for flow division at each bifurcation. By us-
ing these mathematical models, drug carrier distribu-
tions in the tumor microvasculature were computed at
microvascular-network level (Frieboes et al. 2013; Curtis et al.
2015).
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Previous mathematical models were focused on the
plasma skimming (Krogh et al. 1922; Pries et al. 1996)
of blood flow at each bifurcation. In the microvascu-
lar transport, red blood cells (RBCs) are concentrated
on the vessel core with cell-free layer (CFL) near the
vessel wall. Due to these two areas, hematocrit level is
changed in following daughter vessels. The subsequent
bifurcating processes change the total distribution of
RBCs and blood flow characteristics in the entire mi-
crovasculature, and this is called the plasma skimming
effect. However, the drug carrier distribution in the mi-
crovasculature is highly dependent on the plasma skim-
ming of blood flow. Hence, it is important to develop a
mathematical model that can predict plasma skimming
effects of both blood and drug carriers considering their
interactions.
Previous studies showed that their interactions de-
pend on numerous factors including drug carriers’ size,
shape, and even vessel geometry (Tan et al. 2013). Both
numerical simulations and experiments indicated clear
interactions between drug carriers and RBCs (Mu¨ller et al.
2014; D’Apolito et al. 2016). Lee et al. studied that the
cross-sectional distribution of drug carriers depend on
their size, and that larger particles tend to marginate
towards vessel walls (Lee et al. 2013). On the other
hand, Muro et al. and also Namdee et al. observed that
larger particles can result in lower targeting efficiency
(Muro et al. 2008; Namdee et al. 2014). These findings
highlight that whilst drug carriers and RBCs clearly
interact with great significance, there is no absolute
rule to describe how they interact and how drug carri-
ers distribute (Champion et al. 2008; Sobczynski et al.
2015). Therefore, it is necessary to study the drug car-
rier distribution and its delivery by coupling it with
plasma skimming and the resulting interactions. More-
over, this must be conducted in a generalized fashion
and also in simplest form for computationally efficient
prediction. In this paper, a generalized plasma skim-
ming model for cells and drug carriers in the microvas-
Fig. 1 Plasma skimming of RBCs at a bifurcation.
culature is suggested. To achieve this goal, the recently
developed plasma skimming model for blood in micro-
circulatory networks (Gould and Linninger 2015) is ap-
plied, and extended to the scope of both cells and drug
carriers. Two cases with different drug carrier distri-
bution condition in a single bifurcation model are con-
sidered to validate the model. Furthermore, the gener-
alized plasma skimming model is tested at microvas-
cular network level for estimating distributions of cells
and drug carriers. In addition, the limitation of current
mathematical model and future perspectives are briefly
discussed.
2 Materials and Methods
2.1 Plasma skimming model for blood
In a parent vessel, blood flow is determined by blood
viscosity, hematocrit, vessel geometry, and pressure drop.
After bifurcation, the blood flow characteristics in the
following daughter vessels are changed due to their di-
ameter reduction. The flow rate in the daughter ves-
sel can be easily calculated by using conservation of
mass with the diameters of daughter vessels. In the
parent vessel, RBCs are concentrated on the core of
microvessel with a certain thickness of CFL. Then, the
thinner daughter vessel, as a side branch, takes less
RBCs and more plasma. On the other hand, the thicker
daughter vessel takes more RBCs and less plasma. As
shown in Fig. 1, the thicker daughter vessel has higher
hematocrit (hemoconcentration) than the parent vessel
and the thinner vessel has lower hematocrit (hemodi-
lution). This phenomenon is called the “plasma skim-
ming”. To model the plasma skimming parametrically,
Gould and Linninger (2015) suggested a drift param-
eter, M . The general steps to determine hematocrit
changes in a bifurcation are as follows:
H1 = H0 −∆H = ζ
b
1
H∗ (1)
H2 = ζ
b
2H
∗ (2)
Q0H0 = Q1H1 +Q2H2 = Q1ζ
b
1H
∗ +Q2ζ
b
2H
∗ (3)
ζbi =
(
Ai
A0
) 1
M
where i = 1, 2 (4)
where H is the hematocrit, ζb is the hematocrit change
coefficient due to plasma skimming, Q is the flow rate,
A is the cross-sectional area of each vessel, and subscrip-
tion 0, 1 and 2 indicate the parent, and two daughter
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Fig. 2 Cross-sectional distributions of RBCs and drug carriers for generalized plasma skimming model. α is the relative
distribution between RBCs and drug carriers. At α = 0, all drug carriers remain in the RBC core. When α is increased, drug
carrier distribution shifts toward CFL.
vessels, respectively. If two daughter vessels have the
same vessel diameter, ζb values for determining hema-
tocrit of daughter vessels are also identical such that
the hematocrit values of daughter vessels are the same
with that of parent vessel. In most cases, however, two
daughter vessels have different diameters. If the diam-
eters of two daughter vessels greatly differ, the thicker
daughter vessel has higher ζb and the thinner daughter
vessel has lower ζb. Note that while ζb is a dimensionless
kinematic quantity relating the relative phase velocities
in terms of the ratio of parent to daughter vessel cross-
sectional areas, the absolute number of ζb does not de-
scribe plasma skimming. Only the relative difference
between ζb of the daughter vessels affects the hemat-
ocrit of daughter vessels. Whilst there are other mathe-
matically simple and validated plasma skimming mod-
els (Pries and Secomb 2005; Guibert et al. 2010), the
model developed by Gould et al. (Gould and Linninger
2015) was considered due to its easy extensibility.
2.2 Generalized plasma skimming model for cells and
drug carriers
The changes in hematocrit due to the plasma skimming
are a special case of mass transport at a bifurcation. In
order to mathematically model the distribution of drug
carriers or any cells, which may not necessarily be the
same as the one of RBCs, a generalized plasma skim-
ming model was constructed by adding a distribution-
shape parameter α to the plasma skimming model of
blood (Gould and Linninger 2015) as follows:
C1 = C0 −∆C = ζ
c
1
C∗ (5)
C2 = ζ
c
2C
∗ (6)
Q0C0 = Q1C1 +Q2C2 = Q1ζ
c
1
C∗ +Q2ζ
c
2
C∗ (7)
ζci = (1−α)
(
Ai
A0
) 1
M
+α
{
1−
(
Ai
A0
) 1
M
}
where i = 1, 2
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Fig. 3 Redistribution of RBCs and drug carriers with α = 0.2 at a bifurcation. Low α indicates drug carriers stay in the RBC
core of parent microvessel. After the bifurcating process, RBCs and drug carriers are redistributed in the daughter vessels.
(a) Schematic diagram of single bifurcation with RBCs and drug carriers. (b) ζb curve for calculating hematocrit in daughter
microvessels. (c) ζc curve for calculating concentration of drug carriers in daughter microvessels.
(8)
where C is the concentration of cells or drug carriers,
ζc is the concentration change coefficient and α is the
shape parameter for cross-sectional distribution of C
in a microvessel, as described in Fig. 2. In the case of
α = 0, all cells or drug carriers are within RBC region,
equivalent to the original plasma skimming model for
RBCs. On the other hand, when α = 1, all cells or drug
carriers are within CFL region. They are redistributed
by the opposite tendency of plasma skimming. In most
cases α is likely to be somewhere between 0 and 1. For
example, in a previous work (Lee et al. 2013), it was
reported that larger particles stay in CFL region and
smaller particles stay in RBC core. In this case, parti-
cle size is proportional to α. Therefore, in such case, α
effectively becomes an indicator to quantify the trans-
port efficiency in capillary beds. In order to simplify
the model, cells or drug carriers were assumed to be
homogeneous in both RBC and CFL regions with α
representing the relative level of cells or drug carriers
in the two regions. The shape parameter α enables the
modeling of drug carrier redistribution after bifurcation
tailored to the characteristics of specific drug carriers,
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Fig. 4 Redistribution of RBCs and drug carriers with α = 0.8 at a bifurcation. High α indicates drug carriers stay in the CFL
area of parent microvessel. After the bifurcating process, RBCs and drug carriers are redistributed in the daughter vessels.
(a) Schematic diagram of single bifurcation with RBCs and drug carriers. (b) ζb curve for calculating hematocrit in daughter
microvessels. (c) ζc curve for calculating concentration of drug carriers in daughter microvessels.
and hence making the model to be very generalized.
Therefore, if α of a specific drug carrier is studied, this
mathematical model can be adjusted on it.
2.3 Coupling the generalized plasma skimming model
with blood flow in the microvasculature
Computing drug carrier distribution by using the gen-
eralized plasma skimming model is simple in a sin-
gle bifurcation case. However, it is challenging to pre-
dict distributions of cells and drug carriers in the en-
tire microvascular network. If one is to consider in-
dividual RBCs and drug carriers in a microvascular
network with thousands of vessel segments, it requires
tremendous amount of computation time with heavy
parallel processing. Furthermore, in vivo experiments
are still challenging to accurately measure the distri-
butions. In order to greatly reduce the computation
time while obtaining feasible solutions, the generalized
plasma skimming model was coupled with the math-
ematical model of blood flow to predict the distribu-
tions. The microvascular network geometry was compu-
tationally generated based on mathematical algorithms,
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Fig. 5 Effects of α and M in a single bifurcation model. The average changes in drug carrier distribution were calculated
for a single bifurcation model with different α and M . (a) Three α values were tested. When α = 0.5, drug carriers in the
parent vessel were uniformly distributed throughout the vessel’s cross-section, hence not producing any change in drug carrier
redistribution. With α < 0.5, since drug carriers are highly accumulated in the RBC core, the concentration of drug carriers
in the larger daughter vessel was increased. On the other hand, for α > 0.5, the concentration of drug carriers in the smaller
daughter vessel was increased up to 14 %. (b) When α = 0.2, the drift parameter, M , effect was investigated by applying three
M values. When M is low, the concentration of drug carriers in the daughter vessels was significantly changed.
not from scanned images, by choosing vessel diameter
(di), vessel length (li) and bifurcation angles (θi and
φi) (Yang et al. 2016). Three diameters for each bi-
furcation (one parent vessel and two daughter vessels)
were governed by dγ
0
= dγ
1
+ dγ
2
where γ was fixed at 3
(Sherman 1981; Murray 1926). For defining the vessels’
lengths from their diameters, the length-to-diameter ra-
tio (β = l/d) was fixed at 25 (Yang et al. 2016). Flow
rates of blood (Qi) were calculated by Poiseuille’s law
and the in vivo viscosity (Pries et al. 1996):
Qi =
pid4i
128µili
∆Pi (9)
µi = µp
[
1 + (µ∗0.45 − 1)
(1−HD)
C
− 1
(1− 0.45)C − 1
×
(
d
d− 1.1
)2](
d
d− 1.1
)2 (10)
µ∗
0.45 = 6e
−0.085d + 3.2− 2.44e−0.06d
0.645
(11)
C = (0.8 + e−0.075d)
(
−1 +
1
1 + 10−11d12
)
+
1
1 + 10−11d12
.
(12)
Here, µi is the apparent viscosity of blood and µp is the
reference viscosity of plasma, fixed at 9 · 10−6 mmHg·s
(Yang and Wang 2013). HD is the discharge hemat-
ocrit, which was calculated by Eqs. (1), (2), (3) and
(4). Also, three flow rates at each bifurcation were cal-
culated by conservation of mass,
∑
Qi = 0. By assum-
ing that the microvascular transport of drug carriers is
independent of the blood flow, the drug carrier distri-
bution can be calculated by explicitly coupling blood
flow rates in microvessels with the generalized plasma
skimming model. Note that the drift parameter, M , is
identical with that for hematocrit calculation, and the
proposed model is fully coupled with hematocrit and
plasma skimming of RBCs.
3 Results
3.1 Plasma skimming of drug carriers in a single
bifurcation model
The single bifurcation model used for testing the plasma
skimming effects is given in Fig. 3a. The diameters of a
parent and two daughter vessels were 40, 33 and 30.38
µm, respectively. The flow rates of three microvessels
were 0.01, 0.006 and 0.004 mm3/s, respectively. In the
parent vessel, the hematocrit (H0) and the concentra-
tion of drug carriers (C0) were given as 45 % and 1 %
of whole blood volume. In microvascular transport, the
concentration of RBCs is increased in the larger daugh-
ter vessel and decreased in the smaller daughter ves-
sel due to the plasma skimming effect. The hematocrit
changes in two daughter vessels were calculated by Eqs.
(1)-(4). The drift parameter, M for in vivo microvas-
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Fig. 6 Representative model of microvascular transport in a microvascular network. The microvasculature geometry was
constructed by a computational algorithm with model parameters, γ = 3 and β = 25 with root vessel diameter = 60 µm. The
pressure drops between the root vessel and the capillary ends were 60 mmHg. (a) Hematocrit distribution along diameter. The
hematocrit distribution was calculated by Gould and Linninger (2015)’s method. (b) Flow rates along diameter. The blood
flow in the microvessels was calculated by Poiseuille’s law with the in vivo viscosity law (Pries et al. 1996).
cular network was fixed at 5.25 as previously reported
(Gould and Linninger 2015).
From the given conditions, hematocrit changes fol-
lowed the curve in Fig. 3b. The hematocrit in larger
daughter vessel was increased to 45.56 % and the hema-
tocrit in smaller daughter vessel was decreased to 44.15
%. In a single bifurcation model, the concentration changes
in drug carriers in two daughter vessels are predicted
by Eqs. (5)-(8). As shown in Fig. 2, drug carriers are
concentrated on the RBC core at α = 0.2. Therefore,
the concentration changes in drug carriers should follow
the same trend of blood hematocrit. The concentration
in the larger daughter vessel, C1 was 1.01% (increased)
and the concentration in the smaller daughter vessel,
C2 was 0.98 % (decreased) (Fig. 3c), hence showing the
expected tendency.
Figure 4a shows the redistribution of RBCs and
drug carriers at α = 0.8. Initial concentration of drug
carriers was low in RBC core and high in CFL, which
means drug carriers tend to easily escape from RBC
core and marginate toward CFL. Then, the plasma skim-
ming at the bifurcation caused drug carriers to accumu-
late in the smaller daughter vessel, or in better words, in
the vessel where there is more CFL. Consequently, the
concentration of drug carriers was decreased in larger
daughter vessel and increased in smaller daughter ves-
sel. The hematocrit changes, ζb, are proportional to the
diameter changes, Ai/A0, as plotted in Fig. 4b. On the
other hand, the concentration changes in drug carriers,
ζc, are inversely proportional to Ai/A0, as described in
Fig. 4c. The concentration of drug carriers in the larger
daughter vessel, C1, was decreased to 0.93 % compared
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Fig. 7 Redistribution of drug carriers in the microvasculature. The drug carrier distribution was calculated by Eqs. (5)-(8).
Three α values were used to predict the redistribution tendency of drug carriers in the computational microvasculature model.
The initial concentration of drug carriers in the root vessel was 0.01. By increasing α, the concentration of drug carriers in the
capillary beds, below 10 µm diameters, was in the range from 0.008 to 0.017, and the average concentration in the capillary
beds was increased.
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to C0 = 1 %. Moreover, the concentration of drug car-
riers in the smaller daughter vessel, C2, was increased
to 1.14 %.
The effect of shape parameter on drug carrier re-
distribution is summarized in Fig. 5a. The initial and
boundary conditions of single bifurcation were the same
with that in Fig. 4a. Note that the concentration changes
at α = 0.5 were zeros for both daughter vessels because
the drug carriers were uniformly distributed in the mi-
crovessel. At α = 0.2, the concentration of drug carriers
was increased by 2 % in the larger daughter vessel and
decreased by 5 % in the smaller daughter vessel. On the
other hand, at α = 0.8, the concentration of drug carri-
ers was decreased by 7 % in the larger daughter vessel
and increased by 14 % in the smaller daughter vessel.
In Fig. 5b, the effect of drift parameter, M , is inves-
tigated at α = 0.2. High M implies well-mixed RBCs
and plasma. LowM implies highly separated RBC core
and CFL. The model was tested with three cases at M
= 3, 5.25 and 8, and the concentration changes in drug
carriers showed increasing tendency for decreasing M .
Intuitively, atM = 3 or lower, separated RBC core and
CFL regions change the distribution of drug carriers. At
M = 8, the well-mixed blood makes the distribution of
drug carriers to stabilize.
3.2 Generalized plasma skimming of drug carriers in
the microvasculature
The generalized plasma skimming model for RBCs and
drug carriers was applied to predict their distributions
in the microvascular network. The mathematically gen-
erated computational microvasculature model mentioned
in Section 2.3 was used. Note that this computational
microvasculature model is limited for generating binary
tree-like structures. However, in vivo capillary beds form
loops, anastomoses, and multifurcations. Therefore, for
a more realistic analysis it is necessary to consider a
true network of microvessels rather than just continu-
ously bifurcating microvessels. Despite such limitation,
this binary tree-like structure is sufficient for studying
drug carrier redistribution in continuously branching
microvessels. For generating a more realistic microvas-
cular network, one can refer to the computational mi-
crovasculature constructed by Linninger et al. (2013).
From the root vessel with 60 µm diameter, the ves-
sel segment was bifurcated ten times until the diam-
eters were decreased to under 10 µm, with β = 25
(Yang et al. 2016). The boundary condition was 60 mmHg
pressure drops between inlet root vessel and outlet cap-
illary ends. For calculating hematocrit distributions,
the drift parameter,M , was fixed at 5.25 (Gould and Linninger
2015). The initial hematocrit in the root vessel was
0.45. Figure 6 shows the hematocrit distributions and
flow rates in the given microvascular network. Unlike
the initial hematocrit in the root vessel, the hematocrit
distribution was significantly changed due to plasma
skimming. In capillary ends, blood hematocrit was in
the range from 0.35 to 0.5. Based on the hematocrit
and in vivo viscosity law, flow rates of blood were cal-
culated and plotted along with diameter in Fig. 6b. Fur-
thermore, the volumetric flow rate was proportional to
vessel diameter, as plotted in Fig. 6b.
In the microvascular transport of blood in the mi-
crovasculature, the distribution of drug carriers was
predicted by Eqs. (5)-(8). The initial volume fraction
of drug carrier was 0.01. Three cross-sectional distribu-
tions of drug carriers, α = 0.2, 0.5 and 0.8, were applied
to the computational microvasculature model. Figure 7
shows the results at α = 0.2, 0.5 and 0.8. When α was
higher, the drug carriers were accumulated in the cap-
illary beds with high variances, ranging from 0.008 to
0.017. From these results, it is expected that highly ac-
cumulated drug carriers in CFL of large root vessels can
move to capillary ends quickly by following the plasma
skimming of blood. For quantitatively evaluating the
average accumulation of drug carriers in the capillary
ends, an average volume fraction is defined as:
C¯ =
1
ncap
ncap∑
i=1
Ci (13)
where C¯ is the average volume fraction of drug carriers
and ncap is the total number of microvessels with di-
ameters below 10 µm. The relative variance of volume
fraction is (C¯ −C0)/C0 × 100 % where C0 is the initial
volume fraction of drug carriers. Note that C0 = 0.01
(or 1%). Figure 8 shows the changes in average volume
fraction for the α range from 0.2 to 0.8. Interestingly,
when α was increased, the average accumulation of drug
carriers in capillary ends was quasi-linearly increased
up to 10% of initial volume fraction. Figure 9 shows
the redistribution of drug carriers in the microvascu-
lar network with respect to hematocrit and diameter.
At α = 0.2, the volume fraction of drug carriers was
slightly changed. However, as plotted in Fig. 9c, in the
case of low hematocrit and small diameter vessel at α
= 0.8, the volume fraction of drug carriers was greatly
increased.
4 Discussion
The generalized plasma skimming model was developed
for predicting the distributions of cells and drug carri-
ers in the microvasculature. As expected, the concentra-
tion of drug carriers in the microvasculature was highly
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Fig. 8 Effect of α in a microvascular system. The average
concentration of drug carriers with different α values was pre-
dicted in the microvascular system. The initial concentration
of drug carriers in the root vessel was assumed to be the same
as the one in the macrocirculation.
changed by the plasma skimming of blood. Firstly, in a
single bifurcation, the redistributions of RBCs and drug
carriers were calculated at two α values, which repre-
sent RBC core concentrated drug carriers (α = 0.2) and
CFL concentrated drug carriers (α = 0.8). Secondly,
the generalized plasma skimming model was applied to
predict the concentration of drug carriers in the mi-
crovasculature. Furthermore, the redistribution of drug
carriers was correlated with hematocrit and their cross-
sectional distribution in the entire microvasculature.
Therefore, if the specific parameters of microvascular
environment are given for targeting diseased areas, the
design of drug carriers can be suggested by this math-
ematical model, specifically by selecting cross-sectional
distribution of drug carriers, called shape parameter, α.
Related to this topic, Thomas et al. (2014) fully dis-
cussed about the effect of vessel bifurcation in deliver-
ing nanoparticles with different sizes. From the experi-
ments, it was found that the drug delivering efficiency
was highly related to the microvascular environment.
However, it is still challenging to quantitatively mea-
sure the concentration of drug carriers in vivo mouse
models. Also, due to the limited information from ex-
periments, it is difficult to decide the design of drug car-
riers for targeting specific microvascular environments.
Hence, the mathematical model of blood flow coupled
with the generalized plasma skimming model can be
used as a predictive tool that can estimate the deliv-
ering efficiency of drug carriers. For the prediction, the
shape parameter, α, can be the indicator for predicting
whether the drug carriers are fast accumulated in the
capillary beds. For example, as plotted in Fig. 8, when
α is below 0.3, the concentration of drug carriers was
lower than the concentration in the macrocirculation.
Therefore, it is possible to give a guideline to enhance
the accumulation in the capillary beds by applying α
of drug carriers. In the current analysis, α = 0.3 was
considered.
It must be noted that the plasma skimming model
developed by Gould et al. is capable of addressing mul-
tifurcations. The proposed method in this study is a
simple extension of the drift flux model. Hence, whilst
this study used a binary tree-like structure for study-
ing drug carrier redistribution, this new model is also
perfectly applicable to multifurcating microvasculature.
Furthermore, by no means this study aims to provide
the drug carrier specific value of shape parameter α and
its physical interpretation. Its interpretation described
in Section 3.2 is only an example of how the drug car-
riers are likely to be redistributed. Such interpretation
is based on the idea that if drug carriers have good
margination, they are likely to move with plasma af-
ter bifurcation, not RBCs in the core, and vice-versa.
This shape parameter α makes the proposed model to
be very generalized. By adjusting only a single param-
eter, the mathematical model can be easily tailored to
a specific drug carrier redistribution problem.
For the correlation between α and targeting effi-
ciency, various parametric studies in silico, in vitro and
in vivo will be required. However, this study was aimed
at developing a mathematical model. To correlate the
current model to a real system, the parameters for the
generalized plasma skimming model must be obtained
from in vitro and in vivo experiments. Also, the correla-
tion between M and α needs to be further investigated
by conducting detailed numerical simulations with in-
dividual RBCs, drug carriers, and blood plasma. By
overcoming all these limitations, it is hoped to utilize
this new model for precisely targeting diseased areas in
microvascular networks.
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Fig. 9 Effect of α along with vessel diameter and hematocrit in a microvascular system. The concentration of drug carriers
are plotted along with hematocrit and vessel diameter. Three α cases were tested in the computational microvascular network
model.
